Supplemental Figure 1 . Serum levels of total and free phenyl sulfate (PS) with AST-120 treatment in patients undergoing maintenance haemodialysis (HD) treatment.
Serial changes in the serum levels of total PS (a: Group I, b: Group II, n = 10 each) and free PS (c: Group I, d: Group II, n = 10 each) with AST-120 treatment.
Supplemental Figure 2 . Serum levels of total and free indoleacetic acid (IAA) with AST-120 treatment in patients undergoing maintenance haemodialysis (HD) treatment.
Serial changes in the serum levels of total IAA (a: Group I, b: Group II, n = 10 each) and free IAA (c: Group I, d: Group II, n = 10 each) with AST-120 treatment.
Supplemental Figure 3 . Serum levels of total and free hippuric acid (HA) with AST-120 treatment in patients undergoing maintenance haemodialysis (HD) treatment.
Serial changes in the serum levels of total HA (a: Group I, b: Group II, n = 10 each) and free HA (c: Group I, d: Group II, n = 10 each) with AST-120 treatment.
Supplemental Figure 4 . Serum levels of urea nitrogen and β2-microglobulin with AST-120 treatment in patients undergoing maintenance haemodialysis (HD) treatment.
Serial changes in the serum levels of urea nitrogen (a: Group I and b: Group II, n = 10 each), and β2-microglobulin (d: Group I and e: Group II, n = 10 each), and the comparison between before and after use of AST-120 at the pre-dialysis session (c:
urea nitrogen, f: β2-microglobulin, n = 20). P values from the Wilcoxon rank sum test. 
